During wound-healing, cells are required to migrate rapidly into the wound site via a proteolytically generated pathway in the provisional matrix, to produce new extracellular matrix, and, subsequently, to remodel the newly formed tissue matrix during the maturation phase. Two classes of molecules cooperate closely to achieve this goal, namely, the matrix adhesion and signaling receptors, the integrins, and matrix-degrading and -processing enzymes, the matrix metalloproteinases (MMPs). There is now substantial experimental evidence that blocking key molecules of either group will prevent or seriously delay wound-healing. It has been known for some time now that cell adhesion by means of the integrins regulates the expression of MMPs. In addition, certain MMPs can bind to integrins or other receptors on the cell surface involved in enzyme activation, thereby providing a mechanism for localized matrix degradation. By proteolytically modifying the existing matrix molecules, the MMPs can then induce changes in cell behavior and function from a state of rest to migration. During wound repair, the expression of integrins and MMPs is simultaneously up-regulated. This review will focus on those aspects of the extensive knowledge of fibroblast and keratinocyte MMPs and integrins in biological processes that relate to wound-healing.
References
1.
Abbey RS, Steffensen B., Overall CM (1997). Protein engineering of the 72-kDa gelatinase collagen binding domain (abstract). J Dent Res76:300.
2.
Agren MS (1994). Gelatinase activity during wound healing. Br J Dermatol131:634-640.
3.
Agren MS (1999). Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds. Arch Dermatol Res291:583-590.
4.
Agrez M., Gu X., Turton J., Meldrum C., Niu J., Antalis T., et al. (1999). The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells. Int J Cancer81:90-97.
5.
Anand-Apte B., Pepper MS, Voest E., Montesano R., Olsen B., Murphy G., et al. (1997). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci38:817-823.
6.
Aplin AE, Howe A., Alahari SK, Juliano RL (1998). Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev50:197-263.
7.
Aplin AE, Howe AK, Juliano R. (1999). Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol11:737-744.
8.
Ashcroft GS, Horan MA, Herrick SE, Tamuzzer RW, Schultz GS, Ferguson MWJ (1997). Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res290:581-591.
9.
Ashworth OJL, Murphy G., Rock MJ, Sherratt MJ, Shapiro SD, Shuttleworth CA, et al. (1999). Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem 340 (Pt 1):171-181.
10.
Azzam HS, Thompson EW (1992). Collagen-induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res52:4540-4544.
11.
Azzo W., Woessner JF (1986). Purification and characterization of an acid metalloproteinase from human articular cartilage. J Biol Chem261:5434-5441.
12.
Banyai L., Patthy L. (1991). Evidence for the involvement of type II domains in collagen binding by 72 kDa type IV procollagenase. FEBS Lett282:23-25.
13.
Banyai L., Tordai H., Patthy L. (1994). The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). Biochem J298:403-407.
14.
Baragi VM, Fliszar CJ, Conroy MC, Ye QZ, Shipley JM, Welgus HG (1994). Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J Biol Chem269:12692-12697.
15.
Bartlett JD, Simmer JP, Xue J., Margolis HC, Moreno EC (1996). Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene183:123-128.
16.
Basbaum CB, Werb Z. ( 1996). Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol8:731-738.
17.
Belien AT, Paganetti PA, Schwab ME (1999). Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol144:373-384.
18.
Benezra M., Vlodsysky I., Ishai-Michaeli R., Neufeld G., Bar-Shavit R. (1993). Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood81:3324-3331.
19.
Bergmann U., Tuuttila A., Stetler-Stevenson WG, Tryggvason K. (1995). Autolytic activation of recombinant human 72 kilodalton type IV collagenase. Biochemistry34:2819-2825.
20.
Bigg HF, Clark IM, Cawston TE (1994). Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates. Biochem Biophys Acta1208:157-165.
21.
Bigg HF, Shi YE, Liu YE, Steffensen B., Overall CM (1997). Specific, high-affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH terminal hemopexin-like domain of human gelatinase A: TIMP-4 binds progelatinase A and the COOH terminal domain in a similar manner to TIMP-2. J Biol Chem272:15496-15500.
22.
Birkedal-Hansen H. (1993). Role of matrix metalloproteinases in human periodontal diseases. J Periodontol64:474-484.
23.
Birkedal-Hansen H., Taylor RE (1982). Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun107:1173-1178.
24.
Birkedal-Hansen H., Moore Wgi, Bodden MK, Windsor LJ, Birkedal-Hansen B., DeCarlo A., et al. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med4:197-250.
25.
Borsi L., Carnemolla B., Nicolo G., Spina B., Tanara G., Zardi L. (1992). Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer52:688-692.
26.
Broberg A., Heino J. (1996). Integrin α2β1-dependent contraction of floating collagen gels and induction of collagenase are inhibited by tyrosine kinase inhibitors. Exp Cell Res228:29-35.
27.
Brooks PC, Stromblad S., Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, et al. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin avp3. Cell85:683-693.
28.
Brown PD, Levy AT, Margulies IMK, Liotta LA, Stetler-Stevenson WG (1990). Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res50:6184-6191.
29.
Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG (1993). Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex. Kidney Int43:163-170.
30.
Bugge TH, Kombrinck KW, Xiao Q., Holmback K., Daugherty CC, Danton MJ, et al. (1996). Loss of fibrinogen rescues mice from pleiotropic effects of plasminogen deficiency. Cell87:709-719.
31.
Bullard KM, Lund L., Mudgett JS, Mellin TN, Hunt TK, Murphy B., et al. (1999). Impaired wound contraction in stromelysin-1 deficient mice. Ann Surg230:260-265.
32.
Butler GS, Will H., Atkinson SJ, Murphy G. (1997). Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem244:653-657.
33.
Butler GS, Butler M., Atkinson SJ, Will H., Tamura T., Schade van Westrum S., et al. (1998). The TIMP-2 membrane type I metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem273:871-880.
34.
Cao J., Sato H., Takino T., Seiki M. (1995). The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem270:801-805.
35.
Cao J., Drews M., Lee HM, Conner C., Bahou WF, Zucker S. (1998). The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. J Biol Chem273:34745-34752.
36.
Carmeliet P., Collen D. (1995). Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis. FASEB J9:934-938.
37.
Carmeliet P., Moons L., Lijnen R., Baes M., Lemaitre V., Tipping P., et al. (1997). Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet17:439-444.
38.
Carmichael DF, Sommer A., Thompson RC, Anderson DC, Smith CG, Welgus HG, et al. (1986). Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA83:2407-2411.
39.
Carragher NO, Levkau B., Ross R., Raines EW (1999). Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of ppl25(FAK), paxillin, and talin. J Cell Biol147:619-630.
40.
Chandler S., Cossins J., Lury J., Wells G. (1996). Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun228:421-429.
41.
Chen WT ( 1996). Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein49(1-3):59-71.
42.
Chiquet M., Matthisson M., Koch M., Tannheimer M., Chiquet-Ehrismann R. (1996). Regulation of extracellular matrix synthesis by mechanical stress. Biochem Cell Biol74:737-744.
43.
Chiquet-Ehrismann R., Tannheimer M., Koch M., Brunner A., Spring J., Martin D. (1994). Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol127:2093-2101.
44.
Chuong CM, Chen HM ( 1991). Enhanced expression of neural cell adhesion molecules and tenascin (Cytotactin) during wound healing. Am J Pathol38:427-440.
45.
Clark IM, Cawston TE (1989). Fragments of human fibroblast collagenase. Purification and characterization. Biochem J263:201-206.
46.
Clark RAF, Spencer J., Larjava H., Ferguson MWJ (1996). Re-epithelialization of normal human excisional wounds is associated with a switch from αvβ5 to αvβ6 integrins. Br J Dermatol135:46-51.
47.
Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. (1988). H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem263:6579-6587.
48.
Collier IE, Krasnov PA, Strongin AY, Birkedal-Hansen H., Goldberg GI (1992). Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDA type IV J Biol Chem267:6776-6781.
49.
Corcoran ML, Stetler-Stevenson WG (1995). Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem270:13453-13459.
50.
Cossins J., Dudgeon TJ, Catlin G., Gearing AJH, Clements JM (1996). Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun228:494-498.
51.
d'Ortho M-P., Will H., Atkinson SJ, Butler G., Messent A., Gavrilovic J., et al. (1997). Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem250:751-757.
52.
Damsky C., Tremble P., Werb Z. ( 1992). Signal transduction via the fibronectin receptor: do integrins regulate matrix remodeling? Matrix Suppl1:184-191.
53.
Davis GE (1992). Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun182:1025-1031.
54.
De Clerck YA, Yean TD, Ratzkin BJ, Lu HS, Langley KE (1989). Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem264:17445-17453.
55.
de Coignac OAB, Elson G., Delneste Y., Magistrelli G., Jeannin P., Aubry JP, et al. (2000). Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem267:3323-3329.
56.
de Melker AA, Sonnenberg A. (1999). Integrins: alternative splicing as a mechanism to regulate ligand binding and integrin signaling events. Bioessays21:499-509.
57.
Decline F., Rousselle P. (2001). Keratinocyte migration requires α2β1 integrin-mediated interaction with the laminin-5 gamma2 chain. J Cell Sci114:811-823.
58.
Defilippi P., Olivo C., Venturino M., Dolce L., Silengo L., Tarone G. (1999). Actin cytoskeleton organization in response to integrin-mediated adhesion. Microsc Res Tech47:67-78.
59.
Di Colandrea T., Wang L., Wille J., D'Armiento J., Chada KK (1998). Epidermal expression of collagenase delays wound-healing in transgenic mice. J Invest Dermatol111:1029-1033.
60.
Dickson R., Willingham MC, Pastan I. (1981). Binding and internalization of 125I-α2-macroglobulin by cultured fibroblasts. J Biol Chem256:3454-3459.
61.
DiMilla PA, Stone JA, Quinn JA, Albelda SM, Lauffenburger DA (1993). Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol122:729-737.
62.
Dumin JA, Dickeson K., Goldberg G., Santoro SA, Parks WC (1999). Interaction among collagenase-1, collagen, and the integrin α2β1 during re-epithelialization (abstract). J Invest Dermatol112:536.
63.
Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M., Roby JD, Santoro SA, et al. (2001). Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha 2beta 1 integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem276:29368-29374.
64.
Edwards DR, Beaudry PP, Laing TD, Kowal V., Leco KJ, Leco PA, et al. (1996). The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes20(Suppl 3):S9-S15.
65.
Ellerbroek SM, Fishman DA, Kearns AS, Bafetti LM, Stack MS (1999). Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res59:1635-1641.
66.
Eming SA, Yarmush ML, Krueger GG, Morgan JR (1999). Regulation of the spatial organization of mesenchymal connective tissue: effects of cell-associated versus released isoforms of platelet-derived growth factor. Am J Pathol154:281-289.
67.
Emmert-Buck MR, Emonard HP, Corcoran ML, Krutzsch HC, Foidart J-M., Stetler-Stevenson WG (1995). Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett364:28-32.
68.
Emonard HP, Remacle AG, Noel AC, Grimaud J-A., Stetler-Stevenson WG, Foidart J-M (1992). Tumor cell surface-associated binding site for the Mr 72,000 type IV collagenase. Cancer Res52:5845-5848.
69.
Esch FS, Ling NC, Bohlen P., Ying SY, Guillemin R. (1983). Primary structure of PDC-109, a major protein constituent of bovine seminal plasma. Biochem Biophys Res Commun113:861-867.
70.
ffrench-Constant C., Van de Water L., Dvorak HF, Hynes RO (1989). Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol109:903-914.
71.
Flaumenhaft R., Rifkin DB (1991). Extracellular matrix regulation of growth factor and protease activity. Curr Opin Cell Biol3:817-823.
72.
Flaumenhaft R., Rifkin DB (1992). The extracellular regulation of growth factor action. Mol Biol Cell3:1057-1065.
73.
Fornaro M., Manzotti M., Tallini G., Slear AE, Bosari S., Ruoslahti E. (1998). BetalC integrin in epithelial cells correlates with a non-proliferative phenotype: forced expression of betalC inhibits prostate epithelial cell proliferation. Am J Pathol153:1079-1087.
74.
Fosang AJ, Last K., Knauper V., Murphy G., Neame PJ (1996). Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett380(1-2):17-20.
75.
Fowlkes JL, Enghild JJ, Suzuki K., Nagase H. (1994). Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem269:25742-25746.
76.
Freije JM, Diez-Itza I., Balbin M., Sanchez LM, Blasco R., Tolivia J., et al. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem269:16766-16773.
77.
Fridman R., Fuerst TR, Hoyhtya M., Oelkuc M., Kraus S., Komarek D., et al. (1992). Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem267:15398-15405.
78.
Fridman R., Toth M., Pena D., Mohashery S. (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res55:2548-2555.
79.
Fukai F., Ohtaki M., Fujii N., Yajima H., Ishii T., Nishizawa Y., et al. (1995). Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry34:11453-11459.
80.
Fulmer HM, Gibson W. (1966). Collagenolytic activity in gingivae of man. Nature209:728-729.
81.
Gailit J., Clark RAF (1996). Studies in vitro on the role of αv and β1 integrins in the adhesion of human dermal fibroblasts to provisional matrix proteins fibronectin, vitronectin, and fibrinogen. J Invest Dermatol106:102-108.
82.
Gailit J., Pierschbacher M., Clark RA (1993). Expression of functional α4β1 integrin by human dermal fibroblasts. J Invest Dermatol100:323-328.
83.
Gailit J., Welch MP, Clark RA (1994). TGF-β1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol103:221-227.
84.
Gailit J., Xu J., Bueller H., Clark RA (1996). Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins α1β1 and α5β1 by human dermal fibroblasts in vitro. J Cell Physiol169:281-289.
85.
Gailit J., Clarke C., Newman D., Tonnesen MG, Mosesson MW, Clark RA (1997). Human fibroblasts bind directly to fibrinogen at RGD sites through integrin αvβ3. Exp Cell Res232:118-126.
86.
Gardner H., Broberg A., Pozzi A., Laato M., Heino J. (1999). Absence of integrin alphalbetal in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J Cell Sci112:263-272.
87.
Giambemardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, et al. (1998). Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol16:483-496.
88.
Giancotti FG (1997). Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr Opin Cell Biol9:691-700.
89.
Giancotti FG, Ruoslahti E. (1999). Integrin signaling. Science285:1028-1032.
90.
Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson WG, Quaranta V. (1997). Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5. Science277:225-228.
91.
Giannelli G., Pozzi A., Stetler-Stevenson WG, Gardner HA, Quaranta V. (1999). Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am J Pathol154:1193-1201.
92.
Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S., He C. (1989). Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA86:8207-8211.
93.
Goldberg GI, Strongin AY, Collier IE, Genrich LT, Marmer BL (1992). Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem267:4583-4591.
94.
Goldfinger LE, Stack MS, Jones JC (1998). Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol141:255-265.
95.
Goldfinger LE, Hopkinson SB, deHart GW, Collawn S., Couchman JR, Jones JC (1999). The a3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci112:2615-2629.
96.
Grant GM, Giambernardi TA, Grant AM, Klebe RJ (1999). Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured cells. Matrix Biol18:145-148.
97.
Greene J., Wang M., Liu YE, Raymond LA, Rosen C., Shi YE (1996). Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem271:30375-30380.
98.
Greiling D., Clark RA (1997). Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci110:861-870.
99.
Grinnell F., Zhu M. (1994). Identification of neutrophil elastase as the proteinase in bum wound fluid responsible for degradation of fibronectin. J Invest Dermatol103:155-161.
100.
Grinnell F., Ho CH, Wysocki A. (1992). Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol98:410-416.
101.
Grinnell F., Zhu M., Carlson MA, Abrams JM (1999). Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res248:608-619.
102.
Grondahl-Hansen J., Lund LR, Ralfkier E., Ottevanger V., Dano K. ( 1988). Urokinase and tissue-type plasminogen activators in keratinocytes during wound re-epithelialization in vivo. J Invest Dermatol90:790-795.
103.
Gross J., Lapiere CM (1962). Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA48:1014-1022.
104.
Gross J., Nagai Y. (1965). Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci USA54:1197-1204.
105.
Gururajan OR, Grenet J., Lahti JM, Kidd VJ ( 1998). Isolation and characterization of two novel metalloproteinase genes linked to the Cdc2L locus on human chromosome 1p36.3. Genomics52:101-106.
106.
Haapasalmi K., Zhang K., Tonnesen M., Olerud J., Sheppard D., Salo T., et al. (1996). Keratinocytes in human wounds express αvβ6 integrin. J Invest Dermatol106:42-48.
107.
Hakkinen L., Heino J., Koivisto L., Larjava H. (1994). Altered interaction of human granulation-tissue fibroblasts with fibronectin is regulated by α5β1 integrin. Biochim Biophys Acta1224:33-42.
108.
Hakkinen L., Uitto V-J., Larjava H. (2000a). Cell biology of gingival wound healing. Periodontology200024(1):127-152.
109.
Hakkinen L., Hildebrand HC, Berndt A., Kosmehl H., Larjava H. (2000b). Immunolocalization of tenascin-C, a9 integrin subunit and αvβ6 integrin during wound healing in human oral mucosa. J Histochem Cytochem48:985-998.
110.
He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, et al. (1989). Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA86:2632-2636.
111.
Hemler ME (1998). Integrin associated proteins. Curr Opin Cell Biol10:578-585.
112.
Hiraoka N., Allen E., Apel IJ, Gyetko MR, Weiss SJ (1998). Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell95:365-377.
113.
Hirose T., Patterson C., Pourmotabbed TF, Mainardi CL, Hasty KA (1993). Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc Natl Acad Sci USA90:2569-2573.
114.
Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov SA, et al. (1999). MTl-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell99:81-92.
115.
Homandberg GA, Meyers R., Xie DL (1992). Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem267:3597-3604.
116.
Howard EW, Bullen EC, Banda MJ (1991). Regulation of the auto-activation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem266:13064-13069.
117.
Howe A., Aplin AE, Alahari SK, Juliano RL (1998). Integrin signaling and cell growth control. Curr Opin Cell Biol10:220-231.
118.
Huang X., Griffiths M., Wu J., Farese RV Jr, Sheppard D. (2000). Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol Cell Biol20:755-759.
119.
Huhtala P., Tuuttila A., Chow LT, Lohi J., Keski-Oja J., Tryggvason K. (1991). Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92-and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem266:16485-16490.
120.
Huhtala P., Humphries MJ, McCarthy JB, Tremble PM, Werb Z., Damsky CH (1995). Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol129:867-879.
121.
Imai K., Shikata H., Okada Y. (1995). Degradation of vitronectin by matrix metalloproteinases-1, -2, -3, -7 and -9. FEBS Lett369(2-3):249-251.
122.
Imai K., Hiramatsu A., Fukushima D., Pierschbacher MD, Okada Y. (1997). Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release. Biochem J322:809-814.
123.
Inoue M., Kratz G., Haegerstrand A., Stahle-Backdal M. (1995). Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol104:479-483.
124.
Ivaska J., Reunanen H., Westermarck J., Koivisto L., Kahari VM, Heino J. (1999). Integrin alpha2betal mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail. J Cell Biol147:401-416.
125.
Jenne D., Stanley KK (1987). Nucleotide sequence and organization of the human S-protein gene: repeating peptide motifs in the "pexin" family and a model for their evolution. Biochemistry26:6735-6742.
126.
Johnson MD, Kim H.-RC, Chesler L., Tsao-Wu G., Bouck N., Polverini P. (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol160:194-202.
127.
Jones PH, Bishop LA, Watt FM ( 1996). Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun4(4-5):297-305.
128.
Jones PL, Crack J., Rabinovitch M. (1997). Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol139:279-293.
129.
Juhasz I., Murphy GF, Yan H.-C, Herlyn M., Albelda SM (1993). Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. Am J Pathol143:1458-1469.
130.
Juliano R. (1996). Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation. Bioessays18:911-917.
131.
Kahari V.-M, Saarialho-Kere UK (1997). Matrix metalloproteinases in skin. Exp Dermatol6:199-213.
132.
Kainulainen T., Hakkinen L., Hamidi S., Larjava K., Kallioinen M., Peltonen J., et al. (1998). Essential role of laminin-5 during re-epithelialization of wounds. J Histochem Cytochem46:353-360.
133.
Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., et al. (2001). Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol153:893-904.
134.
Kapila YL, Kapila S., Johnson PW (1996). Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol15:251-261.
135.
Kapila YL, Lancero H., Johnson PW (1998). The response of periodontal ligament cells to fibronectin. J Periodontol69:1008-1019.
136.
Kapila YL, Wang S., Johnson PW (1999). Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in ppl25(FAK) levels plus proteoglycan-mediated apoptosis via caspases. J Biol Chem274(43):30906-30913.
137.
Khokha R., Waterhouse P., Yagel S., Peeyush KL, Overall CM, Norton G., et al. (1989). Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science243:947-950.
138.
Khokha R., Martin DC, Fata JE ( 1995). Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors. Cancer Metastasis Rev14:97-111.
139.
Kim JP, Zhang K., Chen JD, Kramer RH, Woodley DT (1994). Vitronectin-driven human keratinocyte locomotion is mediated by the αvβ5 integrin receptor. J Biol Chem269:26926-26932.
140.
Kishnani NS, Staskus PW, Yang T.-T, Masiarz FR, Hawkes SP (1995). Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix Biol14:479-488.
141.
Kleiner DE, Stetler-Stevenson WG (1999). Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol43(Suppl):542-551.
142.
Knauper V., Lopez-Otin C., Smith B., Knight G., Murphy G. (1996a). Biochemical characterization of human collagenase-3. J Biol Chem271:1544-1550.
143.
Knauper V., Will H., Lopez-Otin C., Smith B., Atkinson SJ, Stanton H. (1996b). Cellular mechanisms for human procollagenase-3 (MMP-13). activation. J Biol Chem271:17124-17131.
144.
Knauper V., Cowell S., Smith B., Lopez-Otin C., O'Shea M., Morris H., et al. (1997a). The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem272:7608-7616.
145.
Knauper V., Smith B., Lopez-Otin C., Murphy G. (1997b). Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem248:369-373.
146.
Koivisto L., Larjava K., Hakkinen L., Uitto V.-J, Heino J., Larjava H. (1999). Different integrins mediate cell spreading, haptotaxis and lateral migration of HaCat keratinocytes on fibronectin. Cell Adhes Commun7:245-257.
147.
Kolodney MS, Wysolmerski RB (1992). Isometric contraction by fibroblasts and endothelial cells in tissue culture: a quantitative study. Cell Biol117:73-82.
148.
Koshikawa N., Gianelli G., Cirulli V., Miyazaki K., Quaranta V. (2000). Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol148:615-624.
149.
Langholz O., Rockel D., Mauch C., Kozlowska E., Bank I., Krieg T., et al. (1995). Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol131(6 Pt 2):1903-1915.
150.
Larjava H., Lyons JG, Salo T., Makela M., Koivisto L., Birkedal-Hansen H., et al. (1993a). Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J Cell Physiol157:190-200.
151.
Larjava H., Salo T., Haapasalmi K., Kramer RH, Heino J. (1993b). Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest92:1425-1435.
152.
Larjava H., Haapasalmi K., Salo T., Wiebe C., Uitto V.-J (1996). Keratinocyte integrins in wound healing and chronic inflammation of the human periodontium. Oral Dis2:77-86.
153.
Leisner TM, Wencel-Drake JD, Wang W., Lam SC (1999). Bidirectional transmembrane modulation of integrin alpha IIb beta 3 conformations. J Biol Chem274:12945-12949.
154.
Lepage T., Gache C. (1990). Early expression of a collagenase-like hatching enzyme gene in the sea urchin embryo. EMBO J9:3993-3012.
155.
Levi E., Fridman R., Miao HQ, Ma YS, Yayon A., Vlodavsky I. (1996). Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA93:7069-7074.
156.
Levin EG, Santell L. (1987). Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. J Cell Biol105(6 Pt 1):2543-2549.
157.
Libson AM, Gitis AG, Collier IE, Marmer BL, Goldberg GI, Lattman EE (1995). Crystal structure of the hemopexin-like C-terminal domain of gelatinase A. Nature Struct Biol2:938-942.
158.
Liotta LA, Stetler-Stevenson WG (1991). Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res51(Suppl):5054S-5059S.
159.
Llano E., Pendas AM, Knauper V., Sorsa T., Salo T., Salido E., et al. (1997). Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry36:15101-15108.
160.
Llano E., Pendas AM, Freije JM, Nakano A., Knauper V., Murphy G., et al. (1999). Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors. Cancer Res59:2570-2576.
161.
Lobel OP, Dahms NM, Breitmeyer J., Chirgwin JM, Kornfeld S. (1987). Cloning of the bovine 215-kDa cation-independent mannose 6-phosphate receptor. Proc Natl Acad Sci USA84:2233-2237.
162.
Lohi OJ, Wilson CL, Roby JD, Parks WC (2001). Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem276:10134-10144.
163.
Lukashev ME, Werb Z. ( 1998). ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol8:437-441.
164.
Lund LR, Romer J., Bugge TH, Nielsen BS, Frandsen TL, Degen JL, et al. (1999). Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J18:4645-4656.
165.
MacMullen BA, Fujikawa K. (1985). Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor). J Biol Chem260:5328-5341.
166.
Madlener M. (1998). Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds. Arch Dermatol Res290(Suppl):S24-S29.
167.
Madlener M., Parks WC, Werner S. (1998). Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res242:201-210.
168.
Mainiero F., Pepe A., Yeon M., Ren Y., Giancotti FG (1996). The intracellular functions of alpha6beta4 integrin are regulated by EGF. J Cell Biol134:241-253.
169.
Makela M., Salo T., Uitto VJ, Larjava H. (1994). Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res73:1397-1406.
170.
Makela M., Salo T., Larjava H. (1998). MMP-9 from TNFa-stimulated keratinocytes binds to cell surface and type I collagen. Biochem Biophys Res Commun253:325-335.
171.
Makela M., Larjava H., Pirila E., Maisi P., Salo T., Sorsa T., et al. (1999). Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res251:67-78.
172.
Marchenko OGN, Ratnikov BI, Rozanov DV, Godzik A., Deryugina EL, Strongin AY (2001). Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J356 (Pt 3):705-718.
173.
Martin P., Lewis J. (1992). Actin cables and epidermal movement in embryonic wound healing. Nature360:179-183.
174.
Matrisian LM (1992). The matrix-degrading metalloproteinases. Bioessays14:455-463.
175.
Matsuoka Y., Spring J., Ballmer-Hofer K., Hofer U., Chiquet-Ehrismann R. (1990). Differential expression of tenascin splicing variants in the chick gizzard and in cell cultures. Cell Differ Dev32:417-423.
176.
Mauch C., Adelmann-Grill B., Hatamochi A., Krieg T. (1989). Collagenase gene expression in fibroblasts is regulated by a three-dimensional contact with collagen. FEBS Lett250:301-305.
177.
McCaffrey TA, Falcone DJ, Du B. (1992). Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1. J Cell Physiol152:430-440.
178.
McQuibban GA, Gong J-H., Tam E., McCulloch CAG, Clark-Lewis I., Overall CM (2000). Inflammation dampened by gelatinase-A cleavage of monocyte chemoattractant protein-3. Science289:1202-1206.
179.
Messent AJ, Tuckwell DS, Knauper V., Humphries MJ, Murphy G., Gavrilovic J. (1998). Effects of collagenase-cleavage of type I collagen on alpha2betal integrin-mediated cell adhesion. J Cell Sci 111(Pt 8):1127-1135.
180.
Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. (1996). Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest97:761-768.
181.
Miyamoto S., Katz BZ, Lafrenie RM, Yamada KM (1998). Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann NY Acad Sci857:119-129.
182.
Mochitate K., Pawelek P., Grinnell F. (1991). Stress relaxation of contracted collagen gels: disruption of actin filament bundles, release of cell surface fibronectin and down-regulation of DNA and protein synthesis. Exp Cell Res193:198-207.
183.
Monsky WL, Kelly T., Lin C-Y., Yeh Y., Stetler-Stevenson WG, Mueller SC, et al. (1993). Binding and localization of Mr 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res53:3159-3164.
184.
Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, et al. (1987). Insulin-like growth factor II receptor as a multifunctional binding protein. Nature329:301-307.
185.
Motamed K. (1999). SPARC (osteonectin/BM-40). Int J Biochem Cell Biol31:1363-1366.
186.
Munger JS, Harpel JG, Gleizes PE, Mazzieri R., Nunes I., Rifkin DB (1997). Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int51:1376-1382.
187.
Munger JS, Harpel JG, Giancotti FG, Rifkin DB (1998). Interactions between growth factors and integrins: latent forms of transforming growth factor-β are ligands for the integrin αvβ1. Mol Biol Cell9:2627-2638.
188.
Munger JS, Huang X., Kawakatsu H., Griffiths MJ, Dalton SL, Wu J., et al. (1999). The integrin αvβ6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell96:319-328.
189.
Murphy G., Gavrilovic J. (1999). Proteolysis and cell migration: creating a path? Curr Opin Cell Biol11:614-621.
190.
Murphy G., Cockett MI, Stephens PE, Smith BJ, Docherty AJP (1987). Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J248:265-268.
191.
Murphy G., Allan JA, Willenbrock F., Cockett MI, O'Connell JP, Docherty AJP (1992a). The role of the C-terminal domain in collagenase and stromelysin specificity. J Biol Chem267:9612-9618.
192.
Murphy G., Willenbrock F., Ward RV, Cockett MI, Eaton D., Docherty AJP (1992b). The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J283:637-641.
193.
Murphy G., Nguyen Q., Cockett MI, Atkinson SJ, Allan JA, Knight CG, et al. (1994). Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem269:6632-6636.
194.
Nagase H., Enghild JJ, Suzuki K., Salvesen G. (1990). Stepwise activation of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry29:5783-5789.
195.
Nakano T., Scott PG (1987). Partial purification and characterization of a neutral proteinase with collagen telopeptidase activity produced by human gingival fibroblasts. Biochem Cell Biol65:286-292.
196.
Nakahara H., Howard L., Thompson EW, Sato H., Seiki M., Yeh Y., et al. (1997). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA94:7959-7964.
197.
Nelson AR, Fingleton B., Rothenberg ML, Matrisian LM (2000). Matrix metalloproteinases: biologic activity and chemical implications. J Clin Oncol18:1135-1149.
198.
Nicholson R., Murphy G., Breathnach R. (1989). Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases. Biochemistry28:5195-5203.
199.
Niu J., Gu X., Turton J., Meldrum C., Howard EW, Agrez M. (1998). Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem Biophys Res Commun249:287-291.
200.
Ogata Y., Enghild JJ, Nagase H. (1992). Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem267:3581-3584.
201.
Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. (1997). Membrane type 1 metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem272:2446-2451.
202.
Oikarinen AI, Kylmaniemi M., Autio-Harmainen H., Autio P., Salo T. ( 1993). Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelializtion, and decrease by topical glucocorticoids. J Invest Dermatol101:205-210.
203.
Okada A., Tomasetto C., Lutz Y., Bellocq JP, Rio MC, Basset P. (1997). Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol137:67-77.
204.
Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., et al. (1992). Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem267:21712-21719.
205.
Overall CM, Limeback H. (1988). Identification and characterization of enamel proteinases isolated from developing enamel. Biochem J256:965-972.
206.
Overall CM, Sodek J. (1987). Initial characterization of a neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluid. J Dent Res66:1271-1282.
207.
Overall CM, Sodek J. (1990). Concanavalin-A produces a matrix-degradative phenotype in human fibroblasts. Induction/endogenous activation of collagenase, 72 kDa gelatinase, and PUMP-1 is accompanied by suppression of tissue inhibitor of matrix metalloproteinases. J Biol Chem265:21141-21151.
208.
Overall CM, Sodek J. (1992). Reciprocal regulation of collagenase, 72 kDa gelatinase and TIMP gene expression and protein synthesis in human fibroblasts induced by concanavalin A. In: Matrix metalloproteinases and inhibitors. Birkedal-Hansen H, editor. Stuttgart: Gustav Fischer, pp. 209-211.
209.
Overall CM, Wallon UM, Steffensen B., De Clerck Y., Tschesche H., Abbey RS (2000). Substrate and TIMP interactions with human gelatinase A recombinant COOH-terminal hemopexin-like and fibronectin type II-like domains: both the N- and C-domains of TIMP-2 bind the C-domain of gelatinase A. In: Inhibitors of metalloproteinases in development and disease. Edwards D, Hawkes S, Khokha R, editors. Amsterdam, Holland: Gordon & Breach, pp. 57-69.
210.
Palecek SP, Schmidt CE, Lauffenburger DA, Horwitz AF (1996). Integrin dynamics on the tail region of migrating fibroblasts. J Cell Sci 109(Pt 5):941-952.
211.
Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF (1997). Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature385(6616):537-540.
212.
Palecek SP, Huttenlocher A., Horwitz AF, Lauffenburger DA (1998). Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J Cell Sci 111(Pt 7):929-940.
213.
Palecek SP, Horwitz AF, Lauffenburger DA (1999). Kinetic model for integrin-mediated adhesion release during cell migration. Ann Biomed Eng27(2):219-235.
214.
Park OHI, Ni J., Gerkema FE, Liu D., Belozerov VE, Sang QX ( 2000). Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem275:20540-20544.
215.
Parks WC, Mecham RP, editors (1998). Matrix metalloproteinases. San Diego: Academic Press.
216.
Partridge CA, Phillips PG, Niedbala MJ, Jeffrey JJ (1997). Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am J Physiol272(5 Pt 1):L813-L822.
217.
Pei D. (1999). Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Res9:291-303.
218.
Pei D., Weiss SJ (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature375:244-247.
219.
Pei D., Weiss SJ (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem271:9135-9140.
220.
Pendas AM, Knauper V., Puente XS, Llano E., Mattei MG, Apta S., et al. (1997). Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem272:4281-4286.
221.
Petersen MJ, Woodley DT, Stricklin GP, O'Keefe EJ (1990). Enhanced synthesis of collagenase by human keratinocytes cultured on type I or type IV collagen. J Invest Dermatol94:341-346.
222.
Pilcher BK, Duman JA, Sucbeck BD, Krane SM, Welgus HG, Parks WC (1997). The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol137:1445-1457.
223.
Pilcher BK, Sudbeck BD, Dumin JA, Welgus HG, Parks WC (1998). Collagenase-1 and collagen in epidermal repair. Arch Dermatol Res290(Suppl):S37-S46.
224.
Pilcher BK, Wang M., Qin XJ, Parks WC, Senior RM, Welgus HG (1999). Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann NY Acad Sci878:12-24.
225.
Pintucci G., Iacoviello L., Castelli MP, Amore C., Evangelista V., Cerletti C., et al. (1993). Cathepsin G-induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes? J Lab Clin Med122:69-79.
226.
Planus E., Barlovatz-Meimon G., Rogers RA, Bonavaud S., Ingber DE, Wang N. ( 1997). Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading. J Cell Sci110(Pt 9):1091-1098.
227.
Pollanen J., Saksela O., Salonen EM, Andreasen P., Nielsen L., Dano K., et al. (1987). Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol104:1085-1096.
228.
Pourmotabbed TF (1994). Relation between substrate specificity and domain structure of 92-kDa type IV collagenase. Ann NY Acad Sci732:372-374.
229.
Pozzi A., Moberg PE, Miles LA, Wagner S., Soloway P., Gardner HA (2000). Elevated matrix metalloproteinase and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA97:2202-2207.
230.
Prieto AL, Jones FS, Cunningham BA, Crossin KL, Edelman GM (1990). Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization. J Cell Biol111:685-698.
231.
Puente XS, Pendas AM, Llano E., Velasco G., Lopez-Otin C. (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res56:944-949.
232.
Putnins EE, Firth JD, Lohachitranont A., Uitto VJ, Larjava H. (1999). Keratinocyte growth factor (KGF) promotes keratinocyte cell attachment and migration on collagen and fibronectin. Cell Adhes Commun7:211-221.
233.
Pyke C., Ralfkjaer E., Huhtala P., Hurskainen T., Dano K., Tryggvason K. (1992). Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res52:1336-1341.
234.
Pytela R., Pierschbacher MD, Ruoslahti E. (1985). A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci USA82:5766-5770.
235.
Quantin B., Murphy G., Breathnach R. (1989). Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry28:5327-5334.
236.
Raghunath M., Unsold C., Kubitscheck U., Bruckner-Tuderman L., Peters R., Meuli M. (1998). The cutaneous microfibrillar apparatus contains latent transforming growth factor-beta binding protein-1 (LTBP-1) and is a repository for latent TGF-betal. J Invest Dermatol111:559-564.
237.
Raines EW, Lane TF, Iruela-Arispe ML, Ross R., Sage EH ( 1992). The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA89:1281-1285.
238.
Ravanti L., Heino J., Lopez-Otin C., Kahari V-M. (1999a). Induction of collagenase-3 in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem274:2446-2455.
239.
Ravanti L., Hakkinen L., Larjava H., Saarialho-Kere U., Foschi M., Han J., et al. (1999b). Transforming growth factor-β induces collagenase-3 (MMP-13) expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem274:37292-37300.
240.
Reed MJ, Puolakkainen P., Lane TF, Dickerson D., Bornstein P., Sage EH ( 1993). Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem41:1467-1477.
241.
Regen CM, Horwitz AF (1992). Dynamics of beta 1 integrin-mediated adhesive contacts in motile fibroblasts. J Cell Biol119:1347-1359.
242.
Reinartz J., Schafer B., Batrla R., Klein CE, Kramer MD (1995). Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin. Exp Cell Res220:274-282.
243.
Riikonen T., Koivisto L., Vihinen P., Heino J. (1995a). Transforming growth factor-beta regulates collagen gel contraction by increasing alpha 2 beta 1 integrin expression in osteogenic cells. J Biol Chem270:376-382.
244.
Riikonen T., Westermarck J., Koivisto L., Broberg A., Kahari V.-M, Heino J. (1995b). Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen a1(I) gene expression. J Biol Chem270:13548-13552.
245.
Roberts AB, Sporn MB (1996). Transforming growth factor-beta. In: The molecular and cellular biology of wound repair. 2nd ed. Clark RAF, editor. New York: Plenum Press, pp. 275-308.
246.
Romer J., Bugge TH, Pyke C., Lund LR, Flick MJ, Degen JL, et al. (1996). Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med2:287-292.
247.
Rosenfeldt H., Lee DJ, Grinnell F. (1998). Increased c-fos mRNA expression by human fibroblasts contracting stressed collagen matrices. Mol Cell Biol18:2659-2667.
248.
Ruoslahti E. (1999). Fibronectin and its integrin receptors in cancer. Adv Cancer Res76:1-20.
249.
Ruoslahti E., Yamaguchi Y., Hildebrand A., Border WA (1992). Extracellular matrix/growth factor interactions. Cold Spring Harbor Symp Quant Biol57:309-315.
250.
Saarialho-Kere U. (1998). Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res290(Suppl):S47-S54.
251.
Saarialho-Kere U., Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC (1993). Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest92:2858-2866.
252.
Saarialho-Kere U., Pentland AP, Birkedal-Hansen H., Parks WC, Welgus HG (1994). Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest94:79-88.
253.
Saarialho-Kere U., Vaalamo M., Airola K., Niemi K-M., Oikarinen AI, Parks WC (1995). Interstitial collagenase is expressed by keratinocytes that are actively involved in re-epithelialization in blistering skin diseases. J Invest Dermatol104:982-988.
254.
Saito S., Yamaji N., Yasunaga K., Saito T., Matsumoto S., Katoh M., et al. (1999). The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism. J Biol Chem274(43):30756-30763.
255.
Salo T., Makela M., Kylmaniemi M., Autio-Harmainen H., Larjava H. (1994). Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest70:176-182.
256.
Sanchez-Lopez R., Nicholson R., Gesnel MC, Matrisian LM, Breathnach R. (1988). Structure-function relationships in the collagenase family member transin. J Biol Chem263:11892-11899.
257.
Sang QA, Douglas DA (1996). Computational sequence analysis of matrix metalloproteinases. J Protein Chem15:137-160.
258.
Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., et al. (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature370:61-65.
259.
Sato T., del Carmen Ovejero M., Hou P., Heegaard AM, Kumegawa M., Foged NT, et al. (1997). Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci 110(Pt 5):589-596.
260.
Schafer BM, Maier K., Eickhoff U., Todd RF, Kramer MD (1994). Plasminogen activation in healing human wounds. Am J Pathol144(6):1269-1280.
261.
Schiro JA, Chan BM, Roswit WT, Kassner PD, Pentland AP, Hemler ME, et al. (1991). Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell67:403-410.
262.
Schnierer S., Kleine T., Gote T., Hillemann A., Knauper V., Tschesche H. (1993). The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity. Biochem Biophys Res Commun191:319-326.
263.
Schor SL, Ellis I., Banyard J., Schor AM (1999). Motogenic activity of IGD-containing synthetic peptides. J Cell Sci 112(Pt 22):3879-3888.
264.
Schultz-Cherry S., Murphy-Ullrich JE (1993). Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol122:923-932.
265.
Sciubba JJ, Waterhouse JP, Meyer J. (1978). A fine structural comparison of the healing of incisional wounds of mucosa and skin. J Oral Pathol7:214-227.
266.
Scott KA, Wood EJ, Karran EH (1998). A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction. FEBS Lett441:137-140.
267.
Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslahti E., et al. (1992). Role of the αvβ3 integrin in human melanoma cell invasion. Proc Natl Acad Sci USA89:1557-1561.
268.
Seftor Reb, Seftor EA, Stetler-Stevenson WG, Hendrix MJC (1993). The 72 kDa type IV collagenase is modulated via differential expression of αvβ3 and α5β1 integrins during human melanoma cell invasion. Cancer Res53:3411-3415.
269.
Seidah NG, Manjunath P., Rochemont J., Sairam MR, Chretien M. (1987). Complete amino acid sequence of BSP-A3 from bovine seminal plasma. Homology to PDC-109 and to the collagen-binding domain of fibronectin. Biochem J243:195-203.
270.
Seltzer JL, Lee AY, Akers KT, Sudbeck B., Southon EA, Wayner EA, et al. (1994). Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res213:365-374.
Sheetz MP (1994). Cell migration by graded attachment to substrates and contraction. Semin Cell Biol5(3):149-155.
273.
Shipley JM, Doyle GAR, Fliszar CJ, Ye Q-Z., Johnson LL, Shapiro SD, et al. (1996). The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem271:4335-4341.
274.
Shyy JY, Chien S. (1997). Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol9:707-713.
275.
Sinha S., Nevett C., Shuttleworth CA, Kielty CM (1998). Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins. Matrix Biol17(8-9):529-545.
276.
Siri A., Knauper V., Veirana N., Caocci F., Murphy G., Zardi L. (1995). Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem270:8650-8654.
277.
Sodek J., Overall CM (1992). Matrix metalloproteinases in periodontal remodelling. In: Matrix metalloproteinases and inhibitors. Birkedal-Hansen H, editor. Stuttgart: Gustav Fischer, pp. 352-362.
278.
Sonnenberg A., Calafat J., Janssen H., Daams H., van der Raaij-Helmer LM, Falcioni R., et al. (1991). Integrin a6/(34 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol113:907-917.
279.
Søttrup-Jensen L., Birkedal-Hansen H. (1989). Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alphamacroglobulins. J Biol Chem264:393-401.
280.
Springman EB, Angleton EL, Birkedal-Hansen H., Van Wart HE (1990). Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA87:364-368.
281.
Stefansson S., Lawrence DA (1996). The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature383(6599):441-443.
282.
Steffensen B., Martin PA (2001). Ligand binding properties of the fibronectin collagen binding domain. Specific interactions with collagen types I, II, III, IV, V, and X (submitted).
283.
Steffensen B., Wallon UM, Overall CM (1995). Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem270:11555-11566.
284.
Steffensen B., Bigg HF, Overall CM (1998). The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation. J Biol Chem273:20622-20628.
285.
Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989). Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem264:17374-17378.
286.
Stetler-Stevenson WG, Aznavoorian S., Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol9:541-573.
287.
Streuli C. (1999). Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol11:634-640.
288.
Stricklin GP, Li L., Jancic V., Wenczak BA, Nanney LB (1993). Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol143:1657-1666.
289.
Stricklin GP, Li L., Nanney LB (1994). Localization of mRNAs representing interstitial collagenase, 72 kDa gelatinase, and TIMP in healing porcine burn wounds. J Invest Dermatol103:352-358.
290.
Strongin AY, Collier IE, Bannikov G., Marmer BL, Grant GA, Goldberg GI (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem270:5331-5338.
291.
Sudbeck BD, Pilcher BK, Pentland AP, Parks WC (1997a). Modulation of intracellular calcium levels inhibits secretion of collagenase 1 by migrating keratinocytes. Mol Biol Cell8:811-824.
292.
Sudbeck BD, Pilcher BK, Welgus HG, Parks WC (1997b). Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J Biol Chem272:22103-22110.
293.
Suzuki S., Argraves WS, Pytela R., Arai H., Krusius T., Pierschbacher MD, et al. (1986). cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci USA83:8614-8618.
294.
Taipale J., Keski-Oja J. (1997). Growth factors in the extracellular matrix. FASEB J11:51-59.
295.
Taipale J., Saharinen J., Hedman K., Keski-Oja J. (1996). Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem44:875-889.
296.
Takino T., Sato H., Shinagawa A., Seiki M. (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem270:23013-23020.
297.
Taylor ME, Conary JT, Lennartz MT, Stahl PD, Drickamer K. (1990). Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem265:12156-12162.
298.
Tomasek JJ, Halliday NL, Updike DL, Ahem-Moore JS, Vu TK, Liu RW, et al. (1997). Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem272:7482-7487.
299.
Trachslin J., Koch M., Chiquet M. (1999). Rapid and reversible regulation of collagen XII expression by changes in tensile stress. Exp Cell Res247:320-328.
300.
Tremble PM, Damsky CH, Werb Z. ( 1992). Fibronectin fragments, but not intact fibronectin, signalling through the fibronectin receptor induce metalloproteinase gene expression in fibroblasts. Matrix Suppl1:212-214.
301.
Tremble PM, Lane TF, Sage EH, Werb Z. ( 1993). SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol121:1433-1444.
302.
Tremble P., Chiquet-Ehrismann R., Werb Z. ( 1994). The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell5:439-453.
303.
Tremble P., Damsky CH, Werb Z. ( 1995). Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals. J Cell Biol129(6):1707-1720.
304.
Tryggvason K., Hoyhtya M., Pyke C. ( 1993). Type IV collagenases in invasive tumors. Breast Cancer Res Treat24:209-218.
305.
Uitto V-J., Larjava H. (1991). Extracellular matrix molecules and their receptors: an overview with special emphasis on periodontal tissues. Crit Rev Oral Biol Med2:323-354.
306.
Vaalamo M., Weckroth M., Puolakkainen P., Kere J., Saarinen P., Lauharanta J., Saarialho-Kere U. (1996). Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol135:52-59.
307.
Vaalamo M., Mattila L., Johansson N., Kariniemi A-L., Karjalainen-Lindsberg M-L., Kahari VM, et al. (1997). Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol109:96-101.
308.
Vaalamo M., Leivo T., Saarialho-Kere U. (1999). Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3 and -4) in normal and aberrant wound healing. Human Pathol30:795-802.
309.
Van Leuven F., Cassiman J-J., Van den Berghe H. (1979). Demonstration of an 2-macroglobulin receptor in human fibroblasts. Absent in tumor-derived cell lines. J Biol Chem254:5155-5160.
310.
Van Wart HE, Birkedal-Hansen H. (1990). The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA87:5578-5582.
311.
Velasco G., Pendas AM, Fueyo A., Knauper V., Murphy G., Lopez-Otin L. (1999). Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem274:4570-4576.
312.
Wallon UM, Overall CM (1997). The COOH-terminal hemopexin-like domain of human gelatinase A (MMP-2) requires Ca2+ for fibronectin and heparin binding: binding properties of recombinant gelatinase A C-domain to extracellular matrix and basement membrane components. J Biol Chem272:7473-7481.
313.
Wang OX, Yi J., Lei J., Pei D. (1999). Expression, purification and characterization of recombinant mouse MT5-MMP protein products. FEBS Lett462:261-266.
314.
Ward RV, Atkinson SJ, Slocombe PM, Docherty AJP, Reynolds JJ, Murphy G. (1991a). Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochem Biophys Acta1079:242-246.
315.
Ward RV, Hembry RM, Reynolds JJ, Murphy G. (1991b). The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J278:179-187.
316.
Ward RV, Atkinson SJ, Reynolds JJ, Murphy G. (1994). Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem J304:263-269.
317.
Welch MP, Odland GF, Clark RA (1990). Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol110:133-145.
318.
Werb Z., Tremble PM, Behrendtsen O., Crowley E., Damsky CH (1989). Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol109:877-889.
319.
Werb Z., Alexander CM, Adler RR (1992). Expression and function of matrix metalloproteinases in development. In: Matrix metalloproteinases and inhibitors. Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, editors. Stuttgart: Gustav Fischer, pp. 337-343.
320.
Wick M., Burger C., Brusselbach S., Lucibello FC, Muller R. (1994). A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during Gl progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem269:18953-18960.
321.
Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI (1989). SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem264:17213-17221.
322.
Will H., Hinzmann B. (1995). cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem231:602-608.
323.
Willenbrock F., Crabbe T., Slocombe PM, Sutton CW, Docherty AJP, Cockett MI, et al. (1993). The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry32:4330-4337.
324.
Windsor LJ, Birkedal-Hansen H., Birkedal-Hansen B., Engler JA (1991). An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase. Biochemistry30:641-647.
325.
Woessner JF (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J5:2145-2154.
326.
Woessner JF (1994). The family of matrix metalloproteinases. In: Inhibition of matrix metalloproteinases. Therapeutic potential. Greenwald RA, Golub LM, editors. New York: The New York Academy of Sciences, pp. 11-21.
327.
Wolf C., Chenard M-P., de Grossouvre D., Bellocq J-P., Chambon P., Basset P. (1992). Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol99:870-872.
328.
Woodley DT (1996). Re-epithelialization. In: The molecular and cellular biology of wound repair. Clark RAF, editor. New York: Plenum Press, pp. 339-354.
329.
Woodley DT, Bachmann PM, O'Keefe EJ (1988). Laminin inhibits human keratinocyte migration. Cell Physiol136:140-146.
330.
Wysocki AB, Grinnell F. (1990). Fibronectin profiles in normal and chronic wound fluid. Lab Invest63:825-831.
331.
Xie DL, Hui F., Meyers R., Homandberg GA (1994). Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch Biochem Biophys311:205-212.
332.
Xu J., Clark RA (1996). Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol132:239-249.
333.
Xue W., Mizukami I., Todd RF 3rd, Petty HR (1997). Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res57:1682-1689.
334.
Yamamoto K., Yamamoto M. (1994). Cell adhesion receptors for native and denatured type I collagens and fibronectin in rabbit arterial smooth muscle cells in culture. Exp Cell Res214:258-263.
335.
Yamamoto M., Yamato M., Aoyagi M., Yamamoto K. (1995). Identification of integrins involved in cell adhesion to native and denatured type I collagens and the phenotypic transition of rabbit arterial smooth muscle cells. Exp Cell Res219:249-256.
336.
Yang J., Tyler LW, Donoff RB, Song B., Torio AJ, Gallagher GT, et al. (1996). Salivary EGF regulates eosinophil-derived TGF-alpha expression in hamster oral wounds. Am J Physiol270(1 Pt 1):G191-202.
337.
Ye HQ, Azar DT ( 1998). Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci39:913-921.
338.
Yebra M., Goretzki L., Pfeifer M., Mueller BM (1999). Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res250:231-240.
339.
Yu Q., Stamenkovic I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev14:163-176.
Zucker S., Wieman JM, Lysik RM, Wilkie D., Ramamurthy NS, Golub LM, et al. (1987). Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells. Cancer Res47:1608-1614.
